These rates are within the range observed in Fontan patients, which ranged from 3% to 24%.[ 28 , 29 , 30 ] Our meta-analysis demonstrated a nonsignificant trend toward reduced thromboembolic events in patients receiving thromboprophylaxis.
← all excerpts
Efficacy of thromboprophylaxis following stage II surgical palliation for single-ventricle physiology: A systematic review and meta-analysis.
1
—
—